DKNG vs. IBB
DKNG (DraftKings Inc.) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. Over the past 5 years, DKNG returned -14.87%/yr vs 2.67%/yr for IBB. At a 0.39 correlation, their price movements are largely independent.
Performance
DKNG vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DKNG achieves a -32.97% return, which is significantly lower than IBB's 8.92% return.
DKNG
- 1D
- -5.83%
- 1M
- -2.98%
- YTD
- -32.97%
- 6M
- -32.97%
- 1Y
- -45.95%
- 3Y*
- -2.83%
- 5Y*
- -14.87%
- 10Y*
- —
IBB
- 1D
- 1.18%
- 1M
- 8.43%
- YTD
- 8.92%
- 6M
- 6.11%
- 1Y
- 45.34%
- 3Y*
- 13.38%
- 5Y*
- 2.67%
- 10Y*
- 8.88%
DKNG vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
DKNG DraftKings Inc. | -32.97% | -7.37% | 5.53% | 209.48% | -58.54% | -41.00% | 127.19% |
IBB iShares Nasdaq Biotechnology ETF | 8.92% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 23.20% |
Correlation
The correlation between DKNG and IBB is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Apr 24, 2020 | 0.39 |
Over the past year, the correlation between DKNG and IBB has dropped to 0.08 - well below their long-term average of 0.39, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DKNG vs. IBB — Risk / Return Rank
DKNG
IBB
DKNG vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DraftKings Inc. (DKNG) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DKNG | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.19 | ||
| Sortino ratioReturn per unit of downside risk | -4.42 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.37 | -0.54 |
| Calmar ratioReturn relative to maximum drawdown | -0.81 | 4.73 | -5.54 |
| Martin ratioReturn relative to average drawdown | -1.26 | 14.56 | -15.82 |
Loading charts...
Drawdowns
DKNG vs. IBB - Drawdown Comparison
The maximum DKNG drawdown since its inception was -85.73%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for DKNG and IBB.
Loading charts...
Drawdown Indicators
| DKNG | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.73% | -62.85% | -22.88% |
Max Drawdown (1Y)Largest decline over 1 year | -57.04% | -9.63% | -47.41% |
Max Drawdown (3Y)Largest decline over 3 years | -61.26% | -24.85% | -36.41% |
Max Drawdown (5Y)Largest decline over 5 years | -83.87% | -39.82% | -44.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -67.91% | 0.00% | -67.91% |
Average DrawdownAverage peak-to-trough decline | -49.03% | -21.14% | -27.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.37% | 3.12% | +33.25% |
Volatility
DKNG vs. IBB - Volatility Comparison
DraftKings Inc. (DKNG) has a higher volatility of 20.16% compared to iShares Nasdaq Biotechnology ETF (IBB) at 7.18%. This indicates that DKNG's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DKNG | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.16% | 7.18% | +12.98% |
Volatility (6M)Calculated over the trailing 6-month period | 38.14% | 15.89% | +22.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.58% | 20.35% | +28.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.44% | 22.04% | +39.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.33% | 23.17% | +40.16% |
Dividends
DKNG vs. IBB - Dividend Comparison
DKNG has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.22%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DKNG DraftKings Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
DKNG and IBB have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DKNG has higher volatility (20.16%) compared to IBB (7.18%). In terms of maximum drawdown, DKNG dropped -85.73% vs IBB's -62.85%.
IBB currently has the higher Sharpe Ratio (2.24 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DKNG and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer